Not a healthcare professional? Visit our Public site

For South African Healthcare Professionals

Not a healthcare professional? Visit our Public site

This site may contain promotional material

Basket

User logged in

Report Adverse Event

Overlay Text

For South African Healthcare Professionals

Visit our Public site

Event Registration successful

You now have sucesfully register for the event and you can also access the latest updates, events and resources.

In case you would like to receive SMS-reminders for the event you have registered, please scroll down to provide your mobile number.

Account activated – pending validation.

Your account has been activated successfully, but we still need to validate you as a healthcare professional. We’ll send you an email with the result of the validation process in the next [five] days.

In the meantime, you can enjoy access to all the latest news, events and resources on our website

Event registration completed - pending validation.

Your account has been activated successfully, but we still need to validate you as a healthcare professional. We'll send you and email with the result of the validation process in the next [five] days.

In the meantime, you can enjoy access to all the latest news, events and resources on our website

In case you would like to receive sms-reminders for the event you have registered, please update your communication preferences here.

Account activated - pending validation.

In the meantime, you can enjoy the public content on our website

Event Account activated - pending validation.

In the meantime, you can enjoy the public content on our website

In case you would like to receive sms-reminders for the event you have registered, please update your communication preferences here.

already registered

X »

Anoro Ellipta 20 mcg

has been lorem added to your basket

View Basket

Unit for Hours:H

Unit for Minutes: M

Filter redirection page URL: events-3-3.html

Filter Tags:Medical indications|Products|Therapy Area

Filter Tags values when filtered by all Tags:All Medical indications|All Products|All Therapy Area

OutofBox filter category name:Format

Filter Reset all button text:Reset All

Filter Apply button text:Apply

Events registration success message: Registration successfull

Events registration failure message: Registration failure

Events un-registration success message: Un-Registration successfull

Events un-registration failure message: Un-Registration failure

Reset all default value: false

Tag Requirements value: all

Show More Naivagation Values: 10|25|50

Previous Text label: Previous

Next Text label: Next

Show Text label: Show:

Seats left Text: spaces left

No Seats left Text: No spaces left

Text Area Blank copy in Email Template:$ciamTextareaNoCopyEmail

You are now leaving GSK’s website

You are now leaving a GSK Website. By clicking this link, you will be taken to a website that is not owned or controlled by GSK, and GSK is not responsible for the content provided on that site

Continue

Go back

Safety Notifications

Explore our repository of safety notifications published in relation to locally available products.

2026

APRIL 2026

Risk of DRESS associated with levetiracetam

Levetiracetam

Read Now

2025

June 2025

Physical appearance of Avodart Capsules

Dutasteride

Read Now

2024

July 2024

Risk of DRESS associated with aciclovir/valaciclovir-containing medicines

Aciclovir

Read Now

2023

June 2023

Bupropion containing medicines - risk of Brugada syndrome

Bupropion hydrochloride

Read Now

2022

July 2022

Topical corticosteroids - risk of withdrawal reactions

Corticosteroids (topical)

Read Now

2021

June 2021

SSRIs and SNRIs associated with the risk of postpartum haemorrhage

Paroxetine

Read Now

2020

October 2020

Dopaminergic medicines used in the treatment of Parkinson’s Disease: Risk of Dopamine Dysregulation Syndrome

Ropinirole hydrochloride

Read Now

April 2026: NX-ZA-NA-WCNT-250001

To report adverse events associated with the use of GSK product/s, please contact us via either +27 10 300 1000 or email us at aereporting.za@gsk.com.

Healthcare providers are requested to report any suspected adverse drug reactions to SAHPRA via the Med safety APP (Medsafety X SAHPRA) and eReporting platform (http://who-umc.org) found on the SAHPRA website.

©2026 GlaxoSmithKline group of companies or its licensor. All rights reserved. GlaxoSmithKline South Africa (Pty) Ltd (Co. reg. no. 1048/030135/07). No.1 Bridgeway Road, Bridgeways Precinct, Century City, Cape Town, Western Cape, 7441, South Africa.

Sorry, this site is not supported on Android v4.3 and below.

Please update your operating system or use a different device.